Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) EBITDA (2016 - 2025)

Historic EBITDA for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $13.7 million.

  • Icu Medical's EBITDA rose 6657.36% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.9 million, marking a year-over-year increase of 118371.92%. This contributed to the annual value of $43.0 million for FY2024, which is 8823.22% up from last year.
  • Per Icu Medical's latest filing, its EBITDA stood at $13.7 million for Q3 2025, which was up 6657.36% from $10.6 million recorded in Q2 2025.
  • Icu Medical's EBITDA's 5-year high stood at $38.4 million during Q3 2021, with a 5-year trough of -$42.2 million in Q1 2022.
  • In the last 5 years, Icu Medical's EBITDA had a median value of $9.4 million in 2023 and averaged $9.6 million.
  • Over the last 5 years, Icu Medical's EBITDA had its largest YoY gain of 585000.0% in 2023, and its largest YoY loss of 538783.78% in 2023.
  • Icu Medical's EBITDA (Quarter) stood at $23.8 million in 2021, then plummeted by 100.93% to -$222000.0 in 2022, then plummeted by 5387.84% to -$12.2 million in 2023, then soared by 409.37% to $37.7 million in 2024, then tumbled by 63.6% to $13.7 million in 2025.
  • Its last three reported values are $13.7 million in Q3 2025, $10.6 million for Q2 2025, and $12.9 million during Q1 2025.